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Investigate whether polymorphism in the promoter region encoding leptin and leptin 
receptor gene, in normal weight individuals, affects hormonal and appetite responses to 
peanuts.
Materials and methods: Appetite, anthropometric indices, body composition, physical 
activity, dietary intake and leptin, ghrelin and insulin levels were monitored. Polymorphism 
analyses were also carried out. 
Results: None of the treatments led to statistical differences in the analyzed hormones. 
No polymorphism was found for leptin receptor gene, while for leptin gene, 50% of the 
volunteers presented one polymorphic allele and 13% presented both polymorphic alleles. 
These last ones presented lower body fat mass, leptin and ghrelin plasma concentrations, 
and fullness rates. They also presented higher hunger, desire to eat, and desire to eat 
sweet and salty foods. 
Conclusions: Peanut did not affect appetite and presented no different hormonal 
responses, compared to other foods studied. Polymorphic allele carriers in both alleles 
presented higher probability to develop obesity. However, the magnitude of this 
probability could not be measured.
© 2011 Asociación Española de Dietistas-Nutricionistas. Published by Elsevier España, S.L. 
All rights reserved.
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Introduction
Nutrigenetics is the interaction between diet habits and the 
individual genetic profi le1. Therefore, nutrigenetics aims to 
understand how the genetic makeup of an individual 
controls the response to diets, considering underlying 
genetic polymorphisms2.
Polymorphisms refer to the occurrence in the same 
population and at the same time of two or more distinct 
forms of a gene. These forms must occur in more than 1% of 
the individuals of a given population to be called 
polymorphism. Polymorphism is usually caused by changes 
in a single nucleotide in a DNA sequence of a gene (SNP)3.
Peanuts are rich in proteins, unsaturated fat, folic acid, 
magnesium fi bers and antioxidants4. The regular consumption 
of peanuts improves lipid profi les5, thereby lowering 
cardiovascular disease risk. In spite of its high energy 
content, peanut consumption does not promote weight 
gain6,7. The mechanisms responsible for this phenomenon 
have not been fully elucidated, but a strong satiety effect 
has been documented, possibly due to the high fi ber and 
protein content of peanuts8,9.
Appetitive sensations are reportedly modulated by a 
variety of hormones10 that may affect food choice and 
energy intake. Circulating leptin concentrations are 
proportional to body fat content, similarly to insulin 
concentrations, but the latter are also more sensitive to 
recent energy and macronutrient consumption11,12. Insulin 
mediated glucose metabolism stimulates leptin synthesis 
and secretion13. The effective stimuli for ghrelin secretion 
have not been fully understood, but the energy status may 
be important. Fasting increases plasma ghrelin concentration 
while feeding leads to a decline11,14. However, it may be 
also modulated by insulin15,16. Thus, an elevation of post-
prandial insulin could be partly predicted to decreased 
hunger, by stimulating leptin secretion or reducing ghrelin 
secretion. 
This study aimed to identify polymorphisms in the 
promoter region of the gene encoding leptin and leptin 
receptor in normal-weight individuals and to investigate 
whether these polymorphisms affect appetite responses to 
peanuts and also hormonal responses (leptin, insulin and 
ghrelin) in these individuals. 
Materials and methods
Subjects
Forty healthy, lean (BMI <25), non-smoking men (n=20) and 
women (n=20), between 18 and 50 years of age completed 
the study. The participants were recruited at the 
Universidade Federal de Viçosa, Brazil. The following 
enrollment criteria were applied: stable weight, no 
medication use (except oral contraceptives), test foods 
rated as palatable, non restrained eaters, and adoption of a 
regular food pattern. The protocol received approval for 
human subject testing from the university committee on 
ethics, and all subjects signed a consent term agreeing to 
participate in the study.
Experimental design
The volunteers went to the laboratory for reporting once a 
week, for 4 weeks, at their customary midday mealtime. 
They were instructed to eat the same, customary breakfast 
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El polimorfi smo del promotor del gen de la leptina en la posición -2549 disminuye la 
leptina plasmática y aumenta el apetito de los voluntarios con peso normal
Resumen
Objetivo: Identifi car polimorfi smos en la región promotora del gen del receptor de la 
leptina en los individuos con peso normal e investigar si este polimorfi smo afecta a las 
respuestas hormonales y el apetito tras la ingesta de cacahuetes o una mezcla de ingre-
dientes con un aporte de macronutrientes semejante.
Material y método: Se controló el apetito, los índices antropométricos, la composición 
corporal, la actividad física, la ingesta dietética y las concentraciones de leptina, grelina 
e insulina de todos los sujetos. Además, se llevaron a cabo los análisis de polimorfi smo. 
Resultados: Ninguno de los tratamientos dio lugar a una diferencia estadísticamente 
signifi cativa en las hormonas analizadas. No se encontró polimorfi smo del gen del recep-
tor de leptina, pero para el gen de la leptina, el 50% de los voluntarios tenían un alelo 
polimórfi co y el 13%, dos. Estos presentaron menores índices de masa grasa corporal, 
concentraciones plasmáticas de leptina y grelina y tasas de plenitud gástrica. Asimismo, 
tenían más hambre, deseo de comer y deseo de comer algo dulce y salado. 
Conclusiones: Ingerir cacahuetes no afecta al apetito y no produce respuestas hormo-
nales diferentes que con otros alimentos estudiados. Los portadores de alelos polimórfi -
cos en los dos alelos tuvieron mayor probabilidad de sufrir obesidad, aunque no ha sido 
posible evaluar su magnitud.
© 2011 Asociación Española de Dietistas-Nutricionistas. Publicado por Elsevier España, S.L. 
Todos los derechos reservados.
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each morning and to fast between this meal and their arrival 
at the laboratory. In 2 sessions, they consumed either 
peanut (PG) or a mix (MG). In addition, each participant 
completed 2 control sessions, in which the test load 
comprised a portion of the study lunch. 
Test Load
The two treatments were PG – salted peanuts; MG – fi ber 
cereal + crunchy cheese + potato chips. The average 
macronutrient composition was: 330 kcal; 16% carbohydrate; 
17% protein; 67% fat.
The standard lunch comprised a sandwich, banana and 
chocolate. The control treatment was a representative 
portion of lunch. Its caloric content (330 kcal) was similar 
to that of the two study treatments, but differed in its 
macronutrient composition: 50% carbohydrate; 16% protein; 
34% fat.
Diet assessment
In each session, the participants recorded types and amounts 
of foods consumed on the day of the test, and on an 
additional week and weekend day. Food records were 
evaluated by the DietPro®, a Brazilian-specifi c nutrient 
database. The intake of energy, carbohydrate, lipid, protein, 
total saturated fatty acid, total polyunsaturated fatty acid, 
total monounsaturated fatty acid and cholesterol was 
estimated according to the food records.
Anthropometric measurements
Height, weight, lean body mass, and total body fat were 
assessed at baseline, while weight was also assessed at each 
session. The participants were weighed in light indoor 
clothing. Bioelectrical impedance was used to determine 
total body fat and the percentage of lean body mass and fat 
mass.
Energy expenditure
The participants received individualized midday meals 
providing 30% of their estimated daily energy need. The 
Institute of Medicine equations (EER) were used to estimate 
energy expenditure17.
Physical activity assessment
The participants maintained 24-hour physical activity logs 
during each session to determine the maintenance of their 
normal activities during the study. The data were analyzed 
using the Nutri Quest® software, version 2.1.
Appetite ratings 
Subjective appetite ratings of hunger, fullness, and desire 
to eat were obtained on 13-point category scales at each 
study session. Scales had end anchors of “not at all” and 
“extremely”. The participants completed the appetite-
rating questionnaire immediately before the consumption 
of test foods and also at 15, 30, 45, 60, 90, 120, 135, 150, 
165, 180, 210, 240, 270 and 300 minutes after it, and hourly, 
for the remaining hours they were awake.
Hormone assays
Blood samples from times 0, 30, 120 and 300 minutes were 
collected and plasma ghrelin, leptin and insulin were 
determined by radioimmunoassay (RIA) in a random sub-
sample of 30 individuals. The samples were analyzed on an 
Auto Logic Gamma Counter.
Polymorphism assessment for LEP and LEP-R gene
Total DNA extraction 
Total DNA of 30 patients was extracted from blood cells 
using the GFX Genomic Blood DNA Purifi cation Kit. Then, 
900 μL of RBC lysis solution was added to 300 μL of blood. 
After homogenization, the mixture was incubated for 5 
minutes at room temperature. Then, centrifugation was 
performed at 12 000 rpm for 20 seconds. The supernatant 
was discarded and the pellets containing white blood cells 
were resuspended by vortexing with 500 μL of extraction 
solution. The mixture was incubated again for 5 minutes at 
room temperature and transferred to collection tubes with 
the GFX column for DNA purifi cation and centrifuged at 
8000 rpm for 1 minute.
The collection tube supernatant was discarded and 500 
μL of extraction solution were added in GFX column. After 
centrifugation at 8000 rpm for 1 minute, the supernatant 
was discarded again. Then 500 μL of washing solution were 
added to the GFX column. After centrifugation at 12 000 
rpm for 3 minutes, the supernatant was discarded again. 
The GFX column was transferred to a new collection tube 
and the DNA was eluted from the column using 100 μL of 
Milli-Q water autoclaved at 70 °C after centrifugation at 
8000 rpm for 1 minute. The amount of DNA was estimated 
by electrophoresis in 0.8% agarose gel.
DNA fragment amplifi cation
Amplifi cation reactions were performed in a fi nal volume of 
50 μL containing 1.0 μL of DNA template, 1 μL of each 
primer, 1 μL of dNTP, 10 μL Taq buffer and 0.25 μL of Taq 
DNA polymerase. The primers used in amplifi cation for the 
gene promoter region that encodes leptin hormone were 
LEP F (5’-TTTCCTGTAATTTTCCCGTGAG-3 ‘) and LEP R 
(5’-AAAGCAAAGACAGGCATAAAAA-3’) and the primers used 
in the amplifi cation of DNA fragment containing part of the 
coding region of the gene that encodes leptin receptor were 
LEP-R F (5’-CACATTGTACAATGGAAGCACAAAGTT-3’) and 
LEP-R R (5’-TGTTAAAATCATAGCCATAAGACATCT-3’). 
The amplifi cations were performed in a thermocycler, 
with an initial step of 2 minutes at 94°C, programmed for 
30 cycles of 45 seconds at 94°C, 45 seconds at 56°C and 1 
minute and 30 seconds at 72°C. Next, a step of 5 minutes at 
72°C was carried out.
Precipitation of amplifi ed DNA fragments and cleavage 
with restriction enzymes
The amplifi cation reactions (two per sample) were 
transferred to 1.5 mL Eppendorf tube and received the 
addition of 1.5 μL of 5 M NaCl and 2.5 volumes of ethanol. 
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The mixture was incubated at –20°C for 16 hours. It was 
then centrifuged at 12 000 rpm for 30 minutes and the 
supernatant was discarded. The pellet was washed with 70% 
ethanol and dried at room temperature. Then, the pellet 
was resuspended in 20 μL of Milli-Q water.
Cleavage reactions were performed in a fi nal volume of 25 
μL containing 20 μL of purifi ed DNA fragment, 2.5 μL of 
enzyme buffer and 1 μL of enzyme. The digestion was 
conducted with CfoI enzyme for LEP fragment and HaeIII 
enzyme for LEP-R fragment. The cleavage reaction was 
incubated at 37°C for 4 h and the products generated were 
separated in 2% agarose gel. After electrophoresis, the gel 
was viewed with UV light and photographed. The size marker 
DNA used was PhiX174 digested with HinfI (Promega®).
Statistical analysis
The data were checked for normality by the Kolmogorov-
Smirnov test. Due to the non-normal distribution of the 
data, the analyses were conducted by non-parametric 
tests.
The treatment effects on rank procedure were tested by 
the ANOVA. Signifi cant effects were further evaluated by 
the Tukey multiple comparisons procedure or Dunn’s test, 
when group sizes differed. The Mann-Whitney test was used 
for between-group comparisons when necessary. The 
criterion level for statistical signifi cance was P<.05, two-




All volunteers presented normal weight and there were no 
signifi cant differences of weight or BMI among the four test 
sessions.
Energy expenditure
The EER median for PG was 2342 kcal/day (n=20) and 
MG=2228 kcal/day (n=20).
Physical activity assessment
The estimated energy expenditure from 24-hour activity 
logs did not differ among the 4 sessions of the study. 
Hormone assays
The MG group presented higher overall hormone 
concentrations. However, no treatment effects were 
observed on hormone concentrations (fi g. 1).
Polymorphism assessment for LEP and LEP-R gene 
The small number of samples in each treatment did not 
allow the performance of the statistical analysis of the data 
for the evaluation of polymorphisms in the leptin gene and 
leptin receptor for each treatment separately.
Since the treatments under study did not affect hormonal 
response differently and the results from group divisions 
were not likely to undergo statistical analysis, we decided 
to perform polymorphism analysis in individuals as a whole, 
only performing separation by polymorphisms.
For leptin gene at the position -2549 in total sample 
(n=30), 37% presented no polymorphism, 50% presented one 
polymorphic allele (AC) and 13% presented both polymorphic 
alleles (AA). Polymorphisms were not found for leptin 
receptor gene.
Polymorphisms in the promoter region of leptin gene 
versus interest parameters
There was no association between gene polymorphism and 
BMI at the position -2549 on leptin gene.
Genotype CC carriers, without the polymorphic allele A, 
presented higher (~20%) fat percentage than other CA and 
AA genotypes (~10%) and, consequently, lower fat-free mass 









































































Figure 1 Comparison of the medians of hormones –ghrelin 
(A), insulin (B) and leptin (C)– present in the four blood with-
drawals from the volunteers from the 2 study treatments du-
ring the 4 study sessions. Medians with different letters are 
statistically different (P<.05).
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plasma leptin levels in various studies18-21, individuals with 
this genotype were expected to have higher percentage of 
fat mass, since leptin is produced in this tissue.
Individuals carrying the polymorphic allele (A) at the 
position -2549 in one or both alleles presented signifi cantly 
lower plasma leptin (AC = 5 ng/mL and AA approximately 
1,8 ng/mL), compared to individuals without this allele (13 
ng/mL). It is worth mentioning that the presence of 
polymorphism in both alleles usually occurred at low values 
of plasma leptin, but this difference was not statistically 
signifi cant, possibly due to the small number of individuals 
belonging to this group.
Regarding plasma ghrelin values, these levels are lower 
(AA, 500 pg/mL, and AC, 600 pg/mL) in individuals with the 
polymorphic allele A, compared to individuals without 
polymorphism (CC, 700 pg/mL).
There was no statistical difference in plasma insulin 
concentrations for polymorphisms at the position -2549 on 
leptin gene, in spite of the trend in AA individuals for lower 
leptin values (AA, 34 μU/mL; AC, 43 μU/mL; CC, 44 μU/
mL).
Figure 2A shows that individuals with polymorphism in 
both alleles (AA) have higher hunger rates and, consequently, 
lower fullness rates (fi g. 2B) than the other genotypes. 
These individuals (AA) presented greater desire to eat than 
the other genotypes (AC and CC) (fi g. 3A). The desire to eat 
sweets and salty foods was higher in patients with the AA 
genotype (fi gs. 3B-D).
Discussion
The presence of polymorphism at the leptin gene promoter 
region has been associated with leptin level fl uctuations. 
Mammés21 described several polymorphisms related to the 
leptin gene. The allele at the position -2549 was associated 
with increased plasma leptin levels before diet restriction, 
and the association did not depend on BMI. The opposite 
effect was found by Le Stunff et al18, who observed that 
women with the AA genotype for the -2549 position 
exhibited lower mean plasma leptin compared to those 
with AC and CC genotypes. It should be observed that none 
of these polymorphisms mentioned above was associated 
with BMI.
In this study, we observed an association between the 
polymorphic allele and lower plasma leptin. However, 
higher levels of the hormone found in patients with CC 
alleles (non-polymorphic) are considered normal, because 
reference values for plasma leptin in normal weight women 
are: 2.0 to 17.0 ng/mL; and in normal weight men are: 1.0 
to 11.0 ng/mL. This result is consistent with the fact that 
these CC individuals presented higher fat mass percentage 
since leptin is a hormone produced by fat cells. Therefore, 
individuals with higher fat stores were expected to produce 
higher amounts of leptin. The AA and AC individuals 
presented lower plasma leptin and, consequently, lower 
body fat percentages. The same fi nding has been reported 
in the literature18,20,21. Obese girls with the AA genotype also 
presented 20 to 25% lower plasma leptin levels, compared 
to other genotypes19.
The values of plasma ghrelin in individuals carrying 
polymorphic allele A were also lower than those for non-
carriers of this allele. However, the magnitude of this 
decrease was considerably smaller (28%) for ghrelin than 
for leptin (75%). This means that these individuals carrying 
the polymorphic allele for leptin promoter at the position 
-2549 tended to present increased food intake and decreased 
satiety. It is not possible to say whether these ghrelin 
concentration values are at normal range or above it for 
this hormone, since there are no reference values available 
for ghrelin because it has been discovered recently. 
However, one can compare these values with other values 
of plasma levels of total ghrelin reported in the literature. 
A study conducted by Leidy et al23 involving non-obese 
women found that control subjects had mean values of total 
24 h ghrelin equal to 1616±122 pg/mL and 1511±173 pg/mL 
for 2 h before and after lunch. These values are very similar 
to the protocol of this study. Aydin et al24 found values well 
below those in their study, with fasting ghrelin in normal 
weight men and women of 126.4±38.5 pg/mL. However, 
Williams et al25 revealed mean values of 24-h ghrelin in 
obese individuals, ranging from 300 pg/mL at 10:00 to 
values close to 500 pg/mL at 18:00. The values found in this 
study varied from 500 to 800 pg/mL for the median of the 
measurements performed after fasting for 4 h and other 
three doses in the postprandial period, totaling 5 h. Due to 
















































Figure 2 Median of hunger rates (A) and fullness rates (B) of 
the volunteers during the 4 study sessions and its relationship 
with leptin gene (LEP) at the position -2549 polymorphism 
(n=30; 50% males and 50% females). C = normal allele, A = po-
lymorphic allele. Medians with different letters are statistically 
signifi cant.
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compare the plasma levels obtained in this study with 
others reported in literature.
The hormone insulin did not show any statistical 
difference for leptin gene at the position -2549 
polymorphisms, although AA individuals tended to lower the 
levels of plasma insulin. The reference values for fasting 
insulin are 3-30 μU/mL. However, for this analysis, 
individuals need to fast for 8 to 14 hours and the volunteers 
of this study had fasted for only 4 hours before the fi rst 
collection, which complicates a more accurate comparison. 
We have found only one study relating this polymorphism 
and plasma insulin concentration. In this study, Ren et al21 
reported that in non-diabetic individuals who had relatives 
with diabetes, the presence of two polymorphic alleles (AA) 
resulted in lower fasting plasma insulin (8.86±5.43 U/mL). 
The same occurrence was observed in the presence of only 
one polymorphic allele (AC) (9.96±4.40 μU/mL) compared 
to individuals without the presence of polymorphism for 
this gene (CC) (11.52±7.51 μU/mL).
The trend of increased food intake and decreased satiety 
when addressing the relationship between polymorphisms 
and hormones is corroborated by the results for appetite. 
They revealed that individuals with polymorphic allele in 
the promoter region on leptin gene at the position -2549 in 
both alleles (AA) have higher rates of hunger than other 
genotypes. This may be partly explained by fi gure 3, which 
shows that the plasma leptin of these volunteers was 
signifi cantly lower, compared to that of individuals without 
polymorphism for this gene.
Leptin is able to inhibit orexigenic peptides (NPY and 
AGRP) while stimulating anorexigenic peptides (POMC and 
CART), thereby causing increased satiety and avoiding 
feeding26,27. Therefore, if individuals with genotype AA had 
lower rates of this hormone, they will probably present 
higher hunger rates and therefore lower fullness rates. These 
individuals (AA) had greater desire to eat than the other 
genotypes (AC and CC), and this desire to eat was higher for 
sweet and salty foods in AA genotype, which ultimately can 
lead to increased caloric intake, promoting weight gain.
The desire for sweets reached values higher than the 
non-specifi c desire to eat, possibly because the desire to 
consume carbohydrates, more specifi cally simple 
carbohydrates, reduces the synthesis of NPY with subsequent 
hunger relief. Once the volunteers were fasting and thus 
having hunger sensations, the craving for sweets would 
eliminate hunger faster28. Anderson et al29 reported that 
carbohydrates with high glycemic index (simple 
carbohydrates) have a greater satiety values and suppress 
hunger more than carbohydrates with low glycemic index 
(complex carbohydrates). This is still a controversial issue, 
since in a study of Alfenas et al30 where 39 healthy adults 
consumed foods with high or low glycemic index, no 
signifi cant differences in appetite were observed (hunger, 
desire to eat and fullness).
The relationship between the results for appetite 
hormone concentrations and polymorphism in the promoter 
region of leptin gene at the position -2549 allows the 














































































































Figure 3 Non-specifi c desire to eat median rates (A); desire to eat sweet foods (B), salty foods (C) and fatty foods (D) during the 
4 study sessions and their relationship with leptin gene (LEP) at the position -2549 polymorphisms (n=30; 50% males and 50% fema-
les). C = normal allele, A = polymorphic allele. Medians with different letters are statistically signifi cant.
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with polymorphism in both alleles. This is due to the fact 
that they have lower plasma leptin concentrations, higher 
hunger rates, lower fullness rates and greater desire to eat, 
mainly sweet foods. However, the magnitude of the 
increased probability to develop obesity could not be 
measured in this study. Therefore, further studies should be 
carried out for a more comprehensive investigation on this 
subject.
Confl ict of interests
The authors declare no confl icts of interests.
References
1. Schuch JB, Voigt F, Maluf SW, Andrade FM. Nutrigenética: a in-
teração entre hábitos alimentares e o perfi l genético indivi-
dual. Rev Bras Bioci. 2010;8:73-84.
2. Mutch DM, Wahli W, Williamson G. Nutrigenomics and nutrige-
netics: the emerging faces of nutrition. FASEB J. 2005;19:1603-
16.
3. Elliott RM, Johnson IT. Nutrigenomic approaches for obesity re-
search. Obes Rev. 2007;8 Suppl 1:77-81.
4. Cruz ACRF. “Balanço energético em indivíduos saudáveis após 
consumo de grão, pasta, farinha ou óleo de amendoim” [Mas-
ter dissertation]. Viçosa: Universidade Federal de Viçosa; 
2006.
5. Alper CM, Mattes RD. Peanut consumption improves indices of 
cardiovascular disease risk in healthy adults. J Am Coll Nutr. 
2003;22:133-41.
6. Hu FB, Stampfer MJ, Manson JE, Rimm EB, Colditz GA, Rosner 
BA, et al. Frequent nut consumption and risk of coronary heart 
disease in women: prospective cohort study. Br J Nutr. 
1998;317:1341-5.
7. Iwamoto M, Sato M, Kono M, Hirooka Y, Sakai K, Takeshita A, et 
al. Walnuts lower serum cholesterol in Japanese men and wo-
men. J Nutr. 2000;130:171-6.
8. Burton-Freeman B. Dietary fi ber and energy regulation. J Nutr. 
2000;130:S272-5.
9. Kirkmeyer SV, Mattes RD. Effects of food attributes on hunger 
and food intake. Int J Obes. 2000;24:1167-75.
10. Degen L, Matzinger D, Drewe J, Beglinger C. The effect of cho-
lecystokinin in controlling appetite and food intake in humans. 
Peptides. 2001;22:1265-9.
11. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, 
Weigle DS. A preprandial rise in plasma ghrelin levels suggests 
a role in meal initiation in humans. Diabetes. 2001;50:1714-9.
12. Tschop M, Wawarta R, Riepl RL, Friedrich S, Bidlingmairer M, 
Landgraf R, et al. Post-prandial decrease of circulating human 
ghrelin levels. J Endocrinol Invest. 2001;24:19-21.
13. Mueller WM, Gregoire FM, Stanhope KL, Mobbs CV, Mizuno TM, 
Warden CH, et al. Evidence that glucose metabolism regulates 
leptin secretion from cultured rat adipocytes. Endocrinology. 
1998;139:551-8.
14. Klok MD, Jakobsdottir S, Drent ML. The role of leptin and ghre-
lin in the regulation of food intake and body weight in humans: 
a review. Obes Rev. 2007;8:21-34.
15. Blom WA, Stafl eu A, De Graaf C, Kok FJ, Schaafsma G, Hendriks 
HF. Ghrelin response to carbohydrate-enriched breakfast is re-
lated to insulin. Am J Clin Nutr. 2005;81:367-75.
16. Cummings DE, Frayo RS, Marmonier C, Aubert R, Chapelot D. 
Plasma ghrelin levels and hunger scores in humans initiating 
meals voluntarily without time- and food-related cues. Am J 
Physiol Endocrinol Metab. 2004;287:E297-304.
17. Dietary Guidelines for Americans and the new food pyramid, 
MyPyramid. Washington: Institute of Medicine (IOM); 2005.
18. Le Stunff CL, Bihan CL, Schork NJ, Bougnères PA. Common pro-
moter variant of the leptin gene is associated with changes in 
the relationship between serum leptin and fat mass in obese 
girls. Diabetes. 2000;49:2196-200.
19. Yiannakouris N, Yannakoulia M, Melistas L, Chan JL, Klims-Za-
cas D, Mantzoros CS. The Q223R polymorphism of the leptin 
receptor gene is signifi cantly associated with obesity and pre-
dicts a small percentage of body weight and body composition 
variability. J Clin Endocrinol Metab. 2001;86:4434-9.
20. Hoffstedt J, Eriksson P, Mottagui-Tabar S, Arner P. A polymor-
phism in the leptin promoter region (-2548G/A) infl uences 
gene expression and adiposite tissue secretion of leptin. Horm 
Metab Res. 2002;34:355-9.
21. Ren W, Zhang SH, Wu J, Ni YX. Polymorphism of the leptin gene 
promoter in pedigrees of type 2 diabetes mellitus in Chon-
gqing, China. Chin Med J. 2004;117:558-61.
22. Mammès O, Betoulle D, Aubert R, Giraud V, Tuzet S, Petiet A, et 
al. Novel polymorphisms in the 5’ region of the LEP gene. Dia-
betes. 1998;47:487-9.
23. Leidy HJ, Dougherty KA, Frye BR, Duke KM, Williams NY. Twen-
ty-four-hour ghrelin is elevated after calorie restriction and 
exercise training in non-obese women. Obesity. 2007;15:446-
55.
24. Aydin S, Halifeoglu I, Ozercan IH, Erman F, Kilic N, Aydin S, et 
al. Comparison of leptin and ghrelin levels in plasma and saliva 
of young healthy subjects. Peptides. 2005;26:647-52.
25. Williams DL, Cummings DE. Regulation of ghrelin in physiologic 
and pathophysiologic states. J Nutr. 2005;135:1320-5.
26. Loos RJF, Rankinen T, Chagnon Y, Tremblay A, Perusse L, 
Bouchard C. Polymorphisms in the leptin and leptin receptor 
genes in relation to resting metabolic rate and respiratory quo-
tient in the Québec Family Study. Int J Obes. 2006;30:183-90.
27. Klok MD, Jakobsdottir S, Drent ML. The role of leptin and ghre-
lin in the regulation of food intake and body weight in humans: 
a review. Obes Rev. 2002;8:21-34.
28. York DA, Bray GA. Animal models hyperphagia. En: Bouchard C, 
Bray GA, editors. Regulation of bodyweight: Biological and be-
havioral mechanisms. New York: John Wile & Sons; 1996. p. 
15-31.
29. Anderson GH, Catherine NL, Woodend DM, Wolever TM. Inverse 
association between the effect of carbohydrates on blood glu-
cose and subsequent short-term food intake in young men. Am 
J Clin Nutr. 2002;76:1023-30.
30. Alfenas RCG, Mattes RD. Infl uence of glycemic index/load on 
glycemic response, appetite, and food intake in healthy hu-
mans. Diabetes Care. 2005;28:2123-9.
02 ORIG (3-9).indd   9 27/1/12   13:04:12
